journal article·2022-06Open access

Erythrocyte membrane-camouflaged nanoparticles as effective and biocompatible platform: Either autologous or allogeneic erythrocyte-derived

Jun Dai, Zhaojun Chen, Shixuan Wang, Fan Xia, Xiaoding Lou

Abstract

Erythrocytes are often used for the development of cell membrane camouflaged nanoparticles (NPs) due to their wide range of sources. However, whether the difference between autologous and allogeneic sources for the erythrocyte membranes have an influence on the performance of camouflaged NPs, which is still inconclusive. To this end, we developed two aggregation-induced emission (AIE) photosensitizers camouflaged with erythrocyte membranes (E-M), named E-Mauto@P and E-Mallo@P, which were prepared using autologous- and allogeneic-derived erythrocytes, respectively. In vivo, [email protected] photodynamic therapy (PDT) effectively inhibited tumor growth, and this therapeutic effect did not differ between E-Mauto@P and E-Mallo@P. Importantly, there were no differences between E-Mauto@P and E-Mallo@P treated mice in terms of general condition, organ function or immune system. Both E-Mauto@P and E-Mallo@P have been shown not to cross the placental barrier and do not affect the development of the embryo, which could be a good platform for the treatment of pregnancy-related disorders. These findings provided more detailed evidences for erythrocyte membrane camouflaged NPs as a promising therapeutic platform, since there is no difference in efficacy or biosafety of either autologous or allogeneic erythrocyte-derived NPs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Corneal Surgery and Treatments · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (80)

Show source-provided references
1. Cell/Bacteria-based bioactive materials for cancer immune modulation and precision therapy10.1002/adma.202100241 ↗
2. What affects the biocompatibility of polymers?10.1016/j.cis.2021.102451 ↗
3. Serum albumin ‘camouflage’ of plant virus based nanoparticles prevents their antibody recognition and enhances pharmacokinetics10.1016/j.biomaterials.2016.02.032 ↗
4. Recent trends in cell membrane-cloaked nanoparticles for therapeutic applications10.1016/j.ymeth.2019.12.004 ↗
5. Biocompatibility evolves: phenomenology to toxicology to regeneration10.1002/adhm.202002153 ↗
6. Biodegradable Manganese-Doped calcium phosphate nanotheranostics for traceable cascade reaction-enhanced anti-tumor therapy10.1021/acsnano.9b05836 ↗
7. Improved in vitro and in vivo biocompatibility of graphene oxide through surface modification: poly(acrylic acid)-functionalization is superior to PEGylation10.1021/acsnano.6b00539 ↗
8. Biofabrication of natural hydrogels for cardiac, neural, and bone tissue engineering applications
9. Natural bio-based monomers for biomedical applications: a review10.1186/s40824-021-00208-8 ↗
10. Bioactive potential of natural biomaterials: identification, retention and assessment of biological properties10.1038/s41392-021-00512-8 ↗
11. Cell membrane camouflaged nanoparticles: a new biomimetic platform for cancer photothermal therapy10.2147/IJN.S200284 ↗
12. Recent advances in cell membrane–camouflaged nanoparticles for cancer phototherapy10.1002/smll.201804105 ↗
13. Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment10.1016/j.apsb.2017.11.009 ↗
14. Cell membrane-camouflaged nanoparticles for drug delivery10.1016/j.jconrel.2015.07.019 ↗
15. Unraveling Cell-type-specific targeted delivery of membrane-camouflaged nanoparticles with plasmonic imaging10.1021/acs.nanolett.0c01503 ↗
16. Cell membrane–camouflaged liposomes for tumor cell–selective glycans engineering and imaging in vivo
17. A programmed cell-mimicking nanoparticle driven by potato alkaloid for targeted cancer chemoimmunotherapy10.1002/adhm.202100311 ↗
18. Fighting immune cold and reprogramming immunosuppressive tumor microenvironment with red blood cell membrane-camouflaged nanobullets10.1021/acsnano.0c07721 ↗
19. Erythrocyte membrane-camouflaged PCN-224 nanocarriers integrated with platinum nanoparticles and glucose oxidase for enhanced tumor sonodynamic therapy and synergistic starvation therapy10.1021/acsami.1c05644 ↗
20. Erythrocyte membrane bioengineered nanoprobes via indocyanine green-directed assembly for single NIR laser-induced efficient photodynamic/photothermal theranostics10.1016/j.jconrel.2021.05.025 ↗
21. Erythrocyte membrane-camouflaged carrier-free nanoassembly of FRET photosensitizer pairs with high therapeutic efficiency and high security for programmed cancer synergistic phototherapy
22. Irradiation pretreatment enhances the therapeutic efficacy of platelet-membrane-camouflaged antitumor nanoparticles10.1186/s12951-020-00660-z ↗
23. Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy10.1002/smll.202001704 ↗
24. Paclitaxel-loaded macrophage membrane camouflaged albumin nanoparticles for targeted cancer therapy10.2147/IJN.S244849 ↗
25. Macrophage-membrane-camouflaged disintegrable and excretable nanoconstruct for deep tumor penetration10.1021/acsami.0c17235 ↗
26. Cancer-cell-biomimetic Upconversion nanoparticles combining chemo-photodynamic therapy and CD73 blockade for metastatic triple-negative breast cancer10.1016/j.jconrel.2021.07.021 ↗
27. Cancer cell membrane camouflaged iridium complexes functionalized black-titanium nanoparticles for hierarchical-targeted synergistic NIR-II photothermal and sonodynamic therapy10.1016/j.biomaterials.2021.120979 ↗
28. Carrier-free highly drug-loaded biomimetic nanosuspensions encapsulated by cancer cell membrane based on homology and active targeting for the treatment of glioma
29. Cancer cell membrane camouflaged nanoparticles to realize starvation therapy together with checkpoint blockades for enhancing cancer therapy10.1021/acsnano.8b03788 ↗
30. Imaging of microRNA in living mice10.1002/adma.201807888 ↗
31. Self-assembly of stem cell membrane-camouflaged nanocomplex for microRNA-mediated repair of myocardial infarction injury10.1016/j.biomaterials.2020.120256 ↗
32. Doxorubicin delivered using nanoparticles camouflaged with mesenchymal stem cell membranes to treat colon cancer10.2147/IJN.S242787 ↗
33. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform10.1073/pnas.1106634108 ↗
34. Surface functionalization of gold nanoparticles with red blood cell membranes10.1002/adma.201300638 ↗
35. Cell-membrane-cloaked oil nanosponges enable dual-modal detoxification10.1021/acsnano.9b02773 ↗
36. A biomimetic nanoparticle to “Lure and Kill” phospholipase A210.1002/anie.202002782 ↗
37. Erythrocyte membrane-coated arsenic trioxide-loaded sodium alginate nanoparticles for tumor therapy10.3390/pharmaceutics12010021 ↗
38. Light-activatable red blood cell membrane-camouflaged dimeric prodrug nanoparticles for synergistic photodynamic/chemotherapy10.1021/acsnano.7b08219 ↗
39. Erythrocyte-camouflaged biosensor for α-hemolysin detection10.1016/j.bios.2021.113267 ↗
40. Enhanced isolation of fetal nucleated red blood cells by enythrocyte-leukocyte hybrid membrane-coated magnetic nanoparticles for noninvasive pregnant diagnostics10.1021/acs.analchem.0c03933 ↗
41. A biomimetic nanosponge that absorbs pore-forming toxins10.1038/nnano.2013.54 ↗
42. Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal10.1126/sciadv.aay9035 ↗
43. Advances on erythrocyte-mimicking nanovehicles to overcome barriers in biological microenvironments10.1016/j.addr.2020.09.001 ↗
44. RBC membrane camouflaged semiconducting polymer nanoparticles for near-infrared photoacoustic imaging and photothermal therapy, Micro10.1007/s40820-020-00429-x ↗
45. Intra/extracellular lactic acid exhaustion for synergistic metabolic therapy and immunotherapy of tumors10.1002/adma.201904639 ↗
46. Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy10.1126/sciadv.aaw6870 ↗
47. Red blood cell membrane-camouflaged nanoparticles loaded with AIEgen and Poly(I : C) for enhanced tumoral photodynamic-immunotherapy
48. Anti-tumour effects of red blood cell membrane-camouflaged black phosphorous quantum dots combined with chemotherapy and anti-inflammatory therapy10.1080/21691401.2019.1584110 ↗
49. Erythrocyte-membrane-enveloped perfluorocarbon as nanoscale Artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy10.1002/adma.201701429 ↗
50. Erythrocyte membrane-camouflaged nanoworms with on-demand antibiotic release for eradicating biofilms using near-infrared irradiation
51. Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics10.1002/ctm2.292 ↗
52. Preparation and application of cell membrane-camouflaged nanoparticles for cancer therapy10.7150/thno.20118 ↗
53. Drug Targeting via platelet membrane–coated nanoparticles10.1002/sstr.202000018 ↗
54. Red blood cell membrane-camouflaged tedizolid phosphate-loaded PLGA nanoparticles for bacterial-infection therapy10.3390/pharmaceutics13010099 ↗
55. Study on preparation, characterization and multidrug resistance reversal of red blood cell membrane-camouflaged tetrandrine-loaded PLGA nanoparticles10.1080/10717544.2019.1573861 ↗
56. Natural-killer-cell-inspired nanorobots with aggregation-induced emission characteristics for near-infrared-II fluorescence-guided glioma theranostics10.1021/acsnano.0c03824 ↗
57. In vivo tracking of mesenchymal stem cell-derived extracellular vesicles improving mitochondrial function in renal ischemia–reperfusion injury10.1021/acsnano.9b08207 ↗
58. A biomimetic aggregation-induced emission photosensitizer with antigen-presenting and hitchhiking function for lipid droplet targeted photodynamic immunotherapy10.1002/adma.202102322 ↗
59. Aggregation-induced emission photosensitizers: from molecular design to photodynamic therapy10.1021/acs.jmedchem.9b02014 ↗
60. PEG-polymer encapsulated aggregation-induced emission nanoparticles for tumor theranostics10.1002/adhm.202101036 ↗
61. Practicable applications of aggregation-induced emission with biomedical perspective10.1002/adhm.202100945 ↗
62. Modular design of peptide- or DNA-modified AIEgen probes for biosensing applications10.1021/acs.accounts.9b00348 ↗
63. A biomimetic aggregation-induced emission photosensitizer with antigen-presenting and hitchhiking function for lipid droplet targeted photodynamic immunotherapy10.1002/adma.202102322 ↗
64. Aggregation-induced generation of reactive oxygen species: mechanism and photosensitizer construction10.3390/molecules26020268 ↗
65. Aggregation-Induced Emission (AIE) dots: emerging theranostic nanolights10.1021/acs.accounts.8b00060 ↗
66. Biocompatible AIEgen/p-glycoprotein siRNA@reduction-sensitive paclitaxel polymeric prodrug nanoparticles for overcoming chemotherapy resistance in ovarian cancer10.7150/thno.53828 ↗
67. Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment10.1016/j.apsb.2017.11.009 ↗
68. Charge-reversal polymer nano-modulators for photodynamic immunotherapy of cancer10.1002/anie.202106392 ↗
69. Activatable polymer nanoenzymes for photodynamic immunometabolic cancer therapy10.1002/adma.202007247 ↗
70. Light-triggered in situ gelation to enable robust photodynamic-immunotherapy by repeated stimulations10.1002/adma.201900927 ↗
71. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
72. Immune tolerance induced by immune-homeostatic particles
73. Designing bioactive micro-/nanomotors for engineered regeneration
74. Cellular fluidic-based vascular networks for tissue engineering
75. Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework10.1016/j.biomaterials.2022.121449 ↗
76. Biomimetic nanoerythrosome-coated aptamer–DNA tetrahedron/maytansine conjugates: pH-responsive and targeted cytotoxicity for HER2-positive breast cancer10.1002/adma.202109609 ↗
77. Membrane cholesterol depletion enhances enzymatic activity of cell-membrane-coated metal-organic-framework nanoparticles
78. Nucleic acids induced peptide-based AIE nanoparticles for fast cell imaging10.1016/j.cclet.2020.09.054 ↗
79. NIR light-induced tumor phototherapy using ICG delivery system based on platelet-membrane-camouflaged hollow bismuth selenide nanoparticles10.1016/j.cclet.2019.10.040 ↗
80. Challenges in cell membrane-camouflaged drug delivery systems: development strategies and future prospects10.1016/j.cclet.2021.03.015 ↗